As per the GOI circular on price capping of Orthopaedic Knee implant by NPPA(National Pharmaceutical Pricing Authority), new prices of knee implants have been implemented effective 16th August 2017. For details on knee implant pricing across our hospitals. CLICK HERE | As per GOI’s circular dated 02nd April 2018 on price-capping of stents by NPPA(National Pharmaceutical Pricing Authority), new prices of coronary stents are revised with effect from 01st April, 2018. For details on stent pricing.CLICK HERE


Investor Contacts

Rahul Ranjan

Company Secretary and Compliance Officer

Fortis Healthcare Limited
Fortis Hospital, Sector 62, Phase – VIII,
Mohali, Punjab  - 160062

Tel. No : +91-172-5096001
Fax No : +91-172-5096221

Lt. General Tejinder Singh Shergill

Additional (Independent) Director, Fortis Healthcare Limited


Lt. General Tejinder Singh Shergill PVSM, graduated from the National Defence Academy, Khadakwasla, where he was awarded the President’s Gold Medal. He was commissioned into The Deccan Horse and has over 40 years of experience in the military that included battle during the 1965 and 1971 Indo-Pak conflicts. He was Defence Attaché at the Indian Embassy, Washington DC, USA; later he commanded a Division in Jammu and Kashmir, a Corps in the North-East, both during counter militancy and counter insurgency operations; also, he was Commandant of the Indian Military Academy. He is a former Chairman of the Punjab Public Service Commission.

Currently he is Director and Advisor, University of Petroleum and Energy Studies and a practicing Graduate Life Coach of the International Coaching Federation, USA.

He has a M.Sc. degree from the University of Madras and a Master of Military Arts and Science degree from the United States Command and General Staff College, Kansas, U.S.A. He lectures frequently on Leadership, Motivation, Energy, Terrorism and Insurgency. He is author of the book “Counter insurgency Support to a Host Nation,” Lancer’s Publications, 1987.

He has represented India in Horse Polo and Cycle Polo; and the Services, in Golf. His interests are in coaching, reading, writing, history, political and international affairs and yoga. He was decorated for gallantry during the 1965 Indo-Pak conflict and later, for distinguished services, was awarded the Param Vishisht Seva Medal by the President of India in 2002.

Presently, Lt. General T.S. Shergill, is a Director on the Board of SRL Limited and one of its subsidiary.


Harpal Singh

Harpal Singh is Mentor & Chairman Emeritus, Fortis Healthcare Limited


Harpal Singh is recognized worldwide as a thinker and speaker on the integration of global healthcare. He has a diverse and wide-ranging experience (of over 35 years) in the corporate sector.

Currently he is the Mentor & Chairman Emeritus and a member of the Board of Directors of Fortis Healthcare Limited, Fortis Clinical Research Limited, Religare Enterprises Ltd., and SRL Diagnostics Ltd. He is also Director of Impact Projects Private Ltd and Impact Senior Living Estates Private Limited. He was Non Executive Chairman of India’s largest Pharmaceutical Company, Ranbaxy

He is and has been associated at the Board level with some of India’s most renowned schools which include The Doon School, The Scindia School, The Shriram School, The Yadavindra Public Schools and Salwan Public Schools.  He was a member of the National Round Table on School Education, a member of the Executive Committee and of the Governing Council of Public Health Foundation of India (PHFI), a member of the Board of the Delhi Red Cross Society, a member of the Board of Governors of NIIT University, a member of India-UK Round Table and India-US Strategic dialogue.  He is a Trustee of Indian National Association for the Club of Rome. He is a Member of the Board of Wadhwani Initiative for Sustainable Health (WISH).  He is Founder and Chairman of Nanhi Chhaan Foundation. He was also a member of the Board of Governors of IIT, Indore. Currently he is the Chairman, Save the Children India and Vice Chair, Save the Children International, UK.


An alumnus of The Doon School and an (Hons.) Graduate in Economics from St. Stephens College, New Delhi. A B.S. in Economics and a Masters' in Public Affairs from the California State University at Hayward (C.S.C.H.), California, U.S.A.


Ms. Sabina Vaisoha

Additional (Independent ) Director, Fortis Healthcare Limited


Ms. Sabina Vaisoha, aged 48 Years, holds Bachelors Degree in Arts from Punjab University and has over 15 of experience in various positions with various entities. Ms. Vaisoha has been associated with India’s leading news network, New Delhi Television (NDTV) for over 18 years. During this period, she has been a part of some of the most revolutionary and cutting edge programming and national events like the elections, fiscal budget and awards and is working on various campaigns to spread awareness of important social issues to bring about a change in society.


Dr. Brian W Tempest


Dr. Brian Tempest advises Companies, Banks, Investment Funds, Private Equity & High Net Worth Individuals on their Strategy in Asia based on his wide experience in China, Japan, South East Asia and India where he has lived for the last decade.

Brian is currently Editor of the Journal of Generic Medicines and a Non Executive Director of the United Nations Medicines Patent Pool in Geneva, Switzerland representing the global generic industry.

Brian started working for Ranbaxy Laboratories in 1995 and he held the positions of Regional Director, President, Managing Director and Chief Executive Officer until 2005 when Ranbaxy became the 9th largest Global Generic Pharmaceutical Company. He then became Chief Mentor, Vice Chairman and Non Executive Director until 2008 when he retired. He is one of the few Westerners to have led a Sensex Nifty 50 Indian blue chip MNC and as a result has a valuable insight into India. Brian has also worked for Glaxo as Regional Director-Far East and Regional Director-Middle East & Africa from 1985 to 1992.

He has worked in the Pharmaceutical Industry for the last 43 years and has managed Healthcare Businesses in North America, South America, Europe, Africa, Middle East, Australasia, China, Japan and India and has led many sessions at Investor Meetings held around the world from Tokyo to Las Vegas.

Brian is a Non Executive Director of Religare Capital Markets, SRL Diagnostics Limited, Fortis Healthcare and Glenmark Pharmaceuticals Ltd. Brian speaks at global conferences on the structural changes in the Global Pharmaceutical Marketplace and most of his presentations in the last decade are available on

Brian received a PhD in Chemistry from Lancaster University, UK in 1971 and in 2009 he became Chairman of the Advisory Board for the Lancaster University Management School. He is a Fellow of the Royal Society of Chemistry and a Fellow of the Royal Society of Medicine.


Request an Media Interaction

  1. Ms. Lynette Joy Hepburn Brown has resigned from the Company with effect from April 11, 2017.
  2. Mr. Ravi Umesh Mehrotra has resigned from the Company with effect from April 12, 2017.
  3. Mr. Sunil Godhwani has vacated his office of director with effect from August 4, 2017.
  4. Ms. Shradha Suri Marwah has resigned from the Company with effect from November 14, 2017
  5. Mr. Malvinder Mohan Singh and Dr. Shivinder Mohan Singh have resigned
    from the Company with effect from February 8, 2018.
  6. Ms. Joji Sekhon Gill has resigned from the Company with effect from March 7, 2018.
  7. Dr. Preetinder Singh Joshi resigned with effect from March 19, 2018
  8. Mr. Pradeep Ratilal Raniga resigned with effect from March 22, 2018